New Key Statistics Module, Z-Score and F-Score
NAS:RGNX Key Ratios
| Market Cap $ M | 794.00 |
| Enterprise Value $ M | 601.66 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 2.29 |
| Price/Sales | 7.74 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 90.00 |
| EPS (TTM) $ | -6.02 |
| Beneish M-Score | -3.59 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -2.34 |
| EV-to-EBITDA | -2.51 |
| PEG | -- |
| Shares Outstanding M | 49.04 |
| Net Margin (%) | -291.99 |
| Operating Margin % | -297.12 |
| Pre-tax Margin (%) | -292.15 |
| Quick Ratio | 2.57 |
| Current Ratio | 2.57 |
| ROA % (ttm) | -37.95 |
| ROE % (ttm) | -63.89 |
| ROIC % (ttm) | -71.51 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.81 |
RGNX Number of Guru Trades
RGNX Volume of Guru Trades
Gurus Latest Trades with NAS:RGNX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:RGNX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Regenxbio Inc Insider Transactions
No Available Data
News about NAS:RGNX
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers